CAPTRUST Financial Advisors
ETTX

CAPTRUST Financial Advisors’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,000
Closed -$2K – 4619
2022
Q2 		$2K Buy
+1,000
New +$2K ﹤0.01% 4574
2022
Q1 		– Sell
-1,000
Closed -$2K – 5277
2021
Q4 		$2K Buy
+1,000
New +$2.7K ﹤0.01% 4485

CAPTRUST Financial Advisors's ETTX Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2022, closing a stake of 1,000 shares — an estimated $2K sold.

CAPTRUST Financial Advisors first reported a position in ETTX in Q4 2021 and held it in 2 quarters. The position peaked at $2K in Q2 2022. 0 funds tracked by Wall St. Rank hold ETTX as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,000 Entasis Therapeutics Holdings Inc. shares in Q3 2022, an estimated $2K.
  • CAPTRUST Financial Advisors first reported a position in Entasis Therapeutics Holdings Inc. in Q4 2021 and held it in 2 quarters.
  • CAPTRUST Financial Advisors's Entasis Therapeutics Holdings Inc. position peaked at $2K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.